MANGOCEUTICALS INC. -
0.2045
08-十月-24 12:07:08
15 分钟延时
股票
-0.0132
-6.06%
今日范围
0.1955 - 0.2177
ISIN
N/A
来源
NASDAQ
-
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
03 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
01 10月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
15 8月 2024 08:25:00 条件 Nasdaq GlobeNewswire
-
13 8月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
09 8月 2024 07:15:00 条件 Nasdaq GlobeNewswire
-
MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology
24 7月 2024 07:15:00 条件 Nasdaq GlobeNewswire
-
Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access
18 7月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts
16 7月 2024 07:20:00 条件 Nasdaq GlobeNewswire
-
12 7月 2024 12:30:00 条件 Nasdaq GlobeNewswire
-
MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets
11 7月 2024 07:15:00 条件 Nasdaq GlobeNewswire
-
06 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
04 6月 2024 15:00:00 条件 Nasdaq GlobeNewswire
-
04 6月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
28 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
23 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
21 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
16 5月 2024 15:40:00 条件 Nasdaq GlobeNewswire
-
Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care
25 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >